Trial Profile
A phase II trial of sorafenib in advanced chordoma patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Sep 2015
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Bone cancer
- Focus Therapeutic Use
- 22 Jul 2015 Results published in the Annals of Oncology.
- 03 Jul 2015 New trial record
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.